Concepedia

Author

Toshihiko Torigoe

Sapporo Medical UniversityORCID

Also Known As

Masaharu Nishimura, T Torigoe, T. Torigoe, TOSHIHIKO TORIGOE, Torigoe T., Torigoe, Toshihiko, ToshihiKo Torigoe, Toshihiko TORIGOE, Toshihiko Torigoe, Toshihiko Torigoe (93291)

595

Publications

15.6K

Citations

60

H-Index

168

Concepts

All Affiliations

Sapporo Medical UniversityHokkaido UniversityUniversity of Pennsylvania
TT

About

Toshihiko Torigoe is an author at Sapporo Medical University specializing in medicine, cell biology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

43

111

6.9K

2

Health Sciences

9

9

471

3

Natural Sciences

8

8

295

4

Engineering

2

2

43

5

Public Health

1

1

47

Toshihiko Torigoe

×

226

Publications

12.3K

Citations

58

H-Index

YearCitations

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Franck Pagès, Bernhard Mlecnik, Florence Marliot,

The Lancet

2018

2K

RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated

Atsushi Tanabe, Kenya Tanikawa, Mai Tsunetomi,

Cancer Letters

2016

237

Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase.

Wang Hg, Toshiyuki Miyashita, Shinichi Takayama,

PubMed

1994

233

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

Bernhard Mlecnik, Carlo Bifulco, Gabriela Bindea,

Journal of Clinical Oncology

2020

222

Survivin Expression Is Regulated by Coexpression of Human Epidermal Growth Factor Receptor 2 and Epidermal Growth Factor Receptor via Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Breast Cancer Cells

Hiroko Asanuma, Toshihiko Torigoe, Kenjiro Kamiguchi,

Cancer Research

2005

196

An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.

Yoshihiko Hirohashi, Toshihiko Torigoe, Akiko Maeda,

PubMed

2002

188

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

Tetsuhiro Tsuruma, Fumitake Hata, Toshihiko Torigoe,

Journal of Translational Medicine

2004

179

Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line.

Larry M. Karnitz, Shari L. Sutor, Toshihiko Torigoe,

Molecular and Cellular Biology

1992

172

Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

Hiroyuki Komori, Tetsuya Nakatsura, Satoru Senju,

Clinical Cancer Research

2006

172

CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection

Noriyuki Yamada, Satoshi Oizumi, Eiki Kikuchi,

Cancer Immunology Immunotherapy

2010

170

Page 1